Trial Profile
Effectiveness of sitagliptin against sulphonylureas for type 2 diabetes mellitus among patients inadequately controlled on Metformin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2020
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 Aug 2018 Results (n=23601) assessing the efficacy of sitagliptin compared with sulphonylureas in adults with T2DM, presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
- 19 Sep 2017 New trial record
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes